PharmOncology

Ming-Hei Tai
  • 5.0 (4)
  • Medicine
  • Updated Weekly

A podcast about pharmacy and oncology

  1. 6d ago

    How do ADCs actually work?

    ADCs may not increase the therapeutic window Cancer Cell commentary: https://www.cell.com/cancer-cell/fulltext/S1535-6108(22)00445-7

  2. Sep 30

    Clinical Trial Representativeness in Oncology

    Using myeloma as an example, why trial representativeness has a meaningful clinical impact in oncology DETERMINATION trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2204925 Blood letter: https://ashpublications.org/blood/article/137/21/2987/475530/Incidence-of-skin-hyperpigmentation-in-Black

  3. Sep 23

    Why MMAE beat MMAF

    A story of two antibody drug conjugate payloads

  4. Sep 16

    Sequencing agents in HER2 mutant lung cancer

    How I think agents should be sequenced in HER2 mutant lung cancer. Case report on zongertinib upregulating HER2 receptors: https://pmc.ncbi.nlm.nih.gov/articles/PMC12964209/

  5. Sep 9

    Does levetiracetam makes sense for ICANS?

    Why did we start using an anti-seizure medication for ICANS? Study on levetiracetam: https://ashpublications.org/bloodadvances/article/9/21/5501/546533/Routine-prophylaxis-with-levetiracetam-offers-no

  6. Sep 2

    Is zanidatamab better than trastuzumab in HER2 IHC 2+?

    Thoughts on the HER2 3+ and HER2 2+/ISH+ subgroups for zanidatamab, and its mechanism of action JACOB trial: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30481-9/abstract INNOVATION trial: https://ascopubs.org/doi/10.1200/JCO.2025.43.4_suppl.LBA331 HERIZON-GEA-01: https://www.nejm.org/doi/full/10.1056/NEJMoa2517729 Zanidatamab preclinical study: https://pmc.ncbi.nlm.nih.gov/articles/PMC10011572/N

  7. Aug 26

    ESR1 mutations, elacestrant, imlunestrant, and vepdegestrant

    How ESR1 mutations develop in breast cancer, targeting them, and some differences between elacestrant, imlunestrant, and vepdegestrant

  8. Aug 19

    Explaining CELMoDs in 10 minutes

    Explaining CELMoDs. It's hard to pronounce ubiquitination! JCO article on VTE events in clinical trials: https://ascopubs.org/doi/10.1200/JCO-25-00489

See All (23)

Ratings & Reviews

5
out of 5
4 Ratings

About

A podcast about pharmacy and oncology

Information

  • Creator
    Ming-Hei Tai
  • Years Active
    2026
  • Episodes
    23
  • Rating
    Clean
  • Copyright
    © Ming-Hei Tai
  • Show Website
    PharmOncology

You Might Also Like